Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3701219014 | Substance with interleukin 5 receptor antagonist mechanism of action (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3701220015 | Interleukin 5 receptor antagonist | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3701221016 | Substance with interleukin 5 receptor antagonist mechanism of action | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Interleukin 5 receptor antagonist | Is a | Interleukin receptor antagonist | true | Inferred relationship | Some | ||
| Interleukin 5 receptor antagonist | Has disposition | Interleukin receptor antagonist | false | Inferred relationship | Some | ||
| Interleukin 5 receptor antagonist | Is a | Immunologic agent | true | Inferred relationship | Some | ||
| Interleukin 5 receptor antagonist | Has disposition | Interleukin 5 receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Reslizumab | Is a | True | Interleukin 5 receptor antagonist | Inferred relationship | Some | |
| Mepolizumab | Is a | True | Interleukin 5 receptor antagonist | Inferred relationship | Some | |
| Interleukin 5 receptor antagonist-containing product | Has active ingredient | True | Interleukin 5 receptor antagonist | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR